Strata Critical Medical, Inc. (SRTA)

SRTA · BiotechSign Pipeline

Pipeline Overview

Therapeutic Focus: Biotech / Pharmasrc

Signal Snapshot

Clinical Trials (ClinicalTrials.gov aggregate)

Catalyst Records

Publication on Record

ClinicalTrials.gov aggregate as of 2026-09-29. Source

Recent Publications

Elevated red cell distribution width as a prognostic indicator in critically ill patients with atrial fibrillation and chronic kidney disease. — BMC Cardiovasc Disord (2026) PMID 42277660

Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Strata Critical Medical, Inc..

Full SRTA Data Sign Up Free

Primary Sources

Company identity
Therapeutic indication
Clinical trial aggregate
Publication 42277660

This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.